[ RadSafe ] From another list

Sat Mar 19 16:59:29 CET 2005

Since this will be produced as a drug, it will have an
expiration date.  Thus, routine disposal of current
stocks and production of new material are required,
whether of not the material is ever used.  If there is
only one manufacturer, money is to made.

--- LNMolino at aol.com wrote:

> Date:  March 18, 2005
> For Release: Immediately
> Contact: HHS  Press Office
> (202) 690-6343
> 
> Headline:  HHS AWARDS BIOSHIELD  CONTRACT FOR LIQUID
> POTASSIUM IODIDE
> 
> The Department of Health and Human  Services today
> awarded a $5.7 million
> contract to Fleming & Company,  Pharmaceuticals of
> Fenton, Mo. for the
> manufacture and delivery of 1.7  million pediatric
> doses of liquid potassium
> iodide (KI).  This supply of  liquid KI, which is
> being purchased under the
> BioShield program, would be  used in the event of a
> release of radioactive
> iodine, a commonly produced  material in commercial
> nuclear power facilities.
> 
> 
> The liquid KI  formulation is the first to be
> developed specifically for
> children. Its black  raspberry taste is designed to
> make it more palatable to
> children. Current  adult dose tablets are bitter and
> must be broken into
> pieces to get a child's  dose. The new formulation
> is delivered using a
> graduated  eyedropper.
> 
> "The acquisition of this new and easy-to-administer
> pediatric  KI formulation
> is an important step forward for our nation's
> radiological  preparedness
> program," Assistant Secretary for Public Health
> Emergency  Preparedness
> Stewart Simonson, said.
> 
> Because the thyroid gland rapidly  absorbs any
> iodine in the body, people
> need to take KI soon after an incident  that
> involves the release of
> radioactive iodine, such as could occur in the 
> vicinity of a nuclear
> commercial power facility. The KI saturates the
> thyroid  gland with iodine,
> thus preventing the thyroid from absorbing
> additional,  radioactive iodine.
> However, KI does not prevent the effects of any
> other  radioactive elements.
> 
> Approval of the liquid KI as a pediatric 
> formulation was given last year by
> the Interagency Weapons of Mass  Destruction Medical
> Countermeasures
> Subcommittee. Children are the most  susceptible to
> the dangerous effects of
> radioactive iodine.
> 
> Once it is  delivered to HHS, the pediatric KI will
> be made available to
> states that  submit and receive approval from HHS
> for plans they develop to
> distribute the  new product in communities around
> commercial nuclear power
> plants.
> 
> The  Food and Drug Administration (FDA) has approved
> KI in tablet form as  a
> nonprescription drug for use as a "blocking agent"
> to prevent the  human
> thyroid gland from absorbing radioactive iodine. On
> Jan. 12, 2005, the  FDA
> granted approval to Fleming for their product
> ThyroShieldTM  (Potassium
> Iodide Oral Solution, USP) 65 mg/ml for  children.
> 
> ###
> 
>
******************************************************************************
> *
> 
> Terrorism  Discussion Group Sponsored By:
> 
> The George Washington University
> 
> -  Response to Emergencies and Disasters Institute
> 
> - Emergency Services  Management Graduate Program
> 
> 01-1-703-726-3700 (voice) 01-1-703-726-3737  (fax)
> 
> http://readi.gwu.edu
> 
> http://homelandsecurity.gwu.edu/dhs/home.html
> 
> ***  FAIR USE NOTICE. This message may contain
> copyrighted material the use 
> of which  has not been specifically authorized by
> the copyright owner. This 
> Internet  discussion list is making it available
> without profit to interested 
> individuals  who have expressed a prior interest in
> receiving the included 
> information in  their efforts to advance the
> understanding of literary, educational, 
> political,  and economic issues, for non-profit
> research and educational 
> purposes only. I  believe that this constitutes a
> 'fair use' of the copyrighted 
> material as  provided for in section 107 of the U.S.
> Copyright Law. If you wish 
> to use this  copyrighted material for purposes of
> your own that go beyond 
> 'fair use,' you  must obtain permission from the
> copyright owner.
> 
> For more information go  to:
> http://www.law.cornell.edu/uscode/17/107.shtml
> 
> -  SUBSCRIBE/UNSUBSCRIBE -
> 
> EMAIL PAUL M. MANISCALCO AT PAULM at GWU.EDU WITH  THE
> DESIRED ACTION ~ EITHER - 
> SUBSCRIBE - OR - UNSUBSCRIBE - TERRORISM LIST  TYPED
> IN THE SUBJECT LINE OF 
> YOUR EMAIL  REQUEST
>
******************************************************************************
> *
> 
> 
> Louis N.  Molino, Sr., CET
> FF/NREMT-B/FSI/EMSI
> LNMolino at aol.com
> 979-690-3607  (Home Office)
> 979-690-7550 (IFW Office)
> 979-412-0890 (Cell  Phone)
> 979-690-7562 (IFW Fax)
> 
> "A Texan with a Jersey  Attitude"
> 
> The comments contained in this E-mail are the
> opinions of the  author and the 
> author alone. I in no way ever intend to speak for
> any person or  
> organization that I am in any way whatsoever
> involved or associated with unless  I 
> specifically state that I am doing so. Further this
> E-mail is intended only  for its 
> stated recipient and may contain private and or
> confidential materials  
> retransmission is strictly prohibited unless placed
> in the public domain by the  
> original author.
> _______________________________________________
> You are currently subscribed to the radsafe mailing
> list
> radsafe at radlab.nl
> 
> For information on how to subscribe/unsubscribe and
> other settings visit: 
> http://radlab.nl/cgi-bin/mailman/listinfo/radsafe
> 

+++++++++++++++++++
"A positive attitude may not solve all your problems, but it will annoy
enough people to make it worth the effort." Herm Albright

-- John
John Jacobus, MS
Certified Health Physicist
e-mail:  crispy_bird at yahoo.com

__________________________________________________
Do You Yahoo!?
Tired of spam?  Yahoo! Mail has the best spam protection around 
http://mail.yahoo.com 